Caliper Life Sciences' Second Quarter 2008 Financial Results Conference Call Notice

Caliper Life Sciences' Second Quarter 2008 Financial Results Conference Call
Notice
WEDNESDAY, August 6, 2008 9:00 a.m. EDT

HOPKINTON, Mass., July 23 /PRNewswire-FirstCall/ -- Caliper Life Sciences,
Inc. (Nasdaq: CALP) will conduct a conference call discussing the company's
second quarter 2008 financial results at 9:00 a.m. EDT on Wednesday, August 6.
Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief
Financial Officer, will host the call. Management will discuss operational and
financial results and the company's outlook for the future.
A news release discussing Caliper's second quarter 2008 financial results
will be issued Wednesday, August 6 at approximately 7:00 a.m. EDT.
Participants, please call 888.713.4215 five to ten minutes prior to the
call and use the participant passcode of 30981927. International callers can
access the call by dialing 617.213.4867 and entering the same passcode. You
may also pre-register for the call at
https://www.theconferencingservice.com/prereg/key.process?key=PALUYGE6Q .
A live webcast of the call can be accessed at www.fulldisclosure.com or on
the Caliper website at www.caliperLS.com in the Events section of the Investor
Relations page. A webcast replay of the call will remain available until
Caliper's earnings call for the third quarter of 2008.
Telephone replays of the conference call will be available approximately
two hours after the completion of the call. To access a telephone playback of
the proceedings from August 6 through August 13, dial 888-286-8010 and use
the participant passcode of 48521551. International callers can access the
playback by dialing 617-801-6888 and using the same participant passcode.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies
enabling researchers in the life sciences industry to create life-saving and
enhancing medicines and diagnostic tests more quickly and efficiently. Caliper
is aggressively innovating new technology to bridge the gap between in vitro
assays and in vivo results and then translating those results into cures for
human disease. Caliper's portfolio of offerings includes state-of-the-art
microfluidics, lab automation & liquid handling, optical imaging technologies,
and discovery & development outsourcing solutions. For more information please
visit http://www.caliperLS.com.
SOURCE Caliper Life Sciences, Inc.

Peter McAree, Chief Financial Officer of Caliper Life Sciences, Inc.,
+1-508-497-2215